helpline 01494 601 400

EMA

Clare Pelham comments on new sodium valproate regulations

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.

Epilepsy Society welcomes new measures to ensure no babies are exposed to sodium valproate during pregnancy

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

Epilepsy Society's chief executive Clare Pelham has called today's announcement of new regulatory measures around sodium valproate, 'a landmark moment for all women who have ever been prescribed the epilepsy drug.'

EMA publishes recommendations on sodium valproate

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

New measures to avoid the exposure of unborn babies to the epilepsy drug, sodium valproate have been announced by the safety committee of the European Medicines Agency (EMA).

Why mums with epilepsy get my #votesforwomen

Epilepsy Society's chief executive Clare Pelham explains why mothers who have campaigned relentlessly about equality in women's health, are her inspiration as we celebrate #VotesforWomen

Epilepsy Society's Clare Pelham discusses sodium valproate and EMA public hearing on BBC News

Epilepsy Society CEO Clare Pelham, Deborah Mann and her daughter Branwen on BBC Victoria Derbyshire

Watch and listen to Epilepsy Society's CEO Clare Pelham discussing sodium valproate on various BBC News programmes last week.

Are you aware of risks around sodium valproate? Take part in our survey

Infographic shows that  both young girls and women of childbearing age should be aware of risks around sodium valproate. Pregnant woman and young girl are silhouetted facing each other on a purple background.

New survey launched to assess levels of awareness among women and girls of the potential risks around epilepsy drug, sodium valproate. The survey has been launched by Epilepsy Society, Epilepsy Action and Young Epilepsy.

Public hearing into sodium valproate - your chance to take part

Picture shows a young mum holding a toddler in her arms as they both look felectively out across the water

Women and girls of childbearing age who are taking or have taken sodium valproate, are being invited to apply to take part in a public hearing about the epilepsy drug.

Department of Health stresses commitment to fast access to medication post Brexit

BBC Radio 4 Today programme

The Department of Health issues statement following BBC Radio 4's Today programme looking at impact if Britain withdraws from the European Medicines Agency (EMA).

Subscribe to RSS - EMA